TrialDiabetes care2018

Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial).

Mohammad Shafi Kuchay et al.PubMed ↗Publisher ↗

No numbers read from the abstract.